Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, La Tronche, France.
MAbs. 2010 Sep-Oct;2(5):528-38. doi: 10.4161/mabs.2.5.12545. Epub 2010 Sep 1.
Seventy-five V regions encoded by the sequenced genome of one Macaca mulatta specimen have been identified by homology, and paired with similar human counterparts. When the human V region of each pair presented no allelic polymorphism, it was directly compared with its homolog. This was the case for 37 pairs, and percents of identity ranged between 84 to 97%. When the human V region presented allelic polymorphism, this polymorphism was found to be significantly smaller (p<0.0001, p<0.0001, p = 0.03 for IGHV, IGLV, IGKV regions respectively), 4.2-fold on average, than the differences observed between human and macaque V regions. Similar results were obtained when analysing framework regions (FRs) only. These results, in agreement with others, demonstrate the existence of differences between human and macaque V regions, confirm the need for the humanization of macaque V regions intended for therapeutic use and call into question the validity of patents relying on the "undistinguishable" character of human and macaque V regions or FRs.
通过同源性分析,从一只猕猴的测序基因组中鉴定出了 75 个 V 区,并与相似的人类 V 区进行了配对。当每对人类 V 区没有等位基因多态性时,直接与其同源物进行比较。这种情况发生在 37 对中,同一性百分比在 84%至 97%之间。当人类 V 区出现等位基因多态性时,发现这种多态性明显更小(IGHV、IGLV、IGKV 区分别为 p<0.0001、p<0.0001、p = 0.03),平均为 4.2 倍,比观察到的人类和猕猴 V 区之间的差异小。仅分析框架区(FRs)时也得到了类似的结果。这些结果与其他结果一致,证明了人类和猕猴 V 区之间存在差异,证实了需要对用于治疗目的的猕猴 V 区进行人源化,并质疑依赖于“不可区分”的人类和猕猴 V 区或 FRs 的专利的有效性。